A Prospective, Randomized, Controlled, Multicenter Phase Iii Clinical Trial Of Apatinib Combined With Neoadjuvant Chemoradiotherapy For Patients With Locally Advanced, Her2-Negative, Siewert'S Type Ii-Iii Adenocarcinoma Of Esophagogastric Junction
ANNALS OF ONCOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要